Search

You searched for "imagers"

1623 results found

An uncommon late postoperative complication of combined cataract surgery and intravitreal triamcinolone injection

1 December 2014 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Case report A 64-year-old female with diabetic maculopathy (DMO) underwent phacoemulsification with intraocular lens (IOL) implantation in her right eye combined with intravitreal triamcinolone (IVTA). Diabetes control was poor with HbA1c (IFCC) of 119mmol/mol and blood sugar level of 27mmol/L....

Back-to-back congresses in Africa highlight international collaboration to advance eye health

4 December 2023 | | EYE - General
The ISOO Africa 2023 Congress The first International Society of Ocular Oncology (ISOO) [1] conference to be held in Africa took place in Mombasa, Kenya, from 21-23 August 2023. Participants came from all over Africa, as well as the US,...

Lessons from an unusual case of syphilis

3 August 2023 | | EYE - Vitreo-Retinal
The rise of syphilis transmission rates over the past two decades has been one of public health’s great puzzles. In the UK, the situation has reached epidemic levels, with a 126% increase between 2013 and 2018 [1]. We present a...

Orthoptic slit-lamp

1 August 2014 | | EYE - Paediatrics, EYE - Strabismus
Adaptations are described that allow the slit-lamp to be used to document squint disorders. Changes are made in the observation system, illumination system, for recording clinical findings and visualisation of clinical findings. The author includes the use of minus lens...

In conversation with Emilio Torres-Netto

24 September 2019
We chat to Emilio Torres-Netto from the ELZA Institute, Zurich, Switzerland at ESCRS 2019 about winning the ICO-Allergan Research Fellowship in 2018 and his research. Click the image below to see his answers to our questions.

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

29 March 2023 | glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

New research shows the unhealthy state of access to medicine and medical devices for blind patients

30 April 2025 | RNIB, The Safety Gap, risk assessment, diabetes, patient experience, public awareness
Blind and partially sighted people could become ill from medicines and medical devices, because they are not being listened to when it comes to designing, prescribing and administering treatments. The Safety Gap’ report commissioned by the Patient Safety Commissioner, Prof...

Designing ophthalmology services Part 3: How do we address the queues post‑COVID-19?

5 August 2020 | | EYE - Cataract, EYE - Refractive, EYE - Vitreo-Retinal, EYE - General
Part 1 of this series available herePart 2 of this series available here There is going to be enormous demand on ophthalmology services as they start to welcome patients back. The authors explain how modelling can help make the most...

What not to miss in neuro-ophthalmology Part 1

1 April 2018 | EYE - Neuro-ophthalmology
Neuro-ophthalmology is a complex and difficult subspecialty in ophthalmology. It has several connections to neurology, neuro-surgery, rheumatology as well as many other medical specialties. Working in an multidisciplinary team (MDT) environment is key to success in this subspecialty as mistakes...

Ocular bubbly: a vitreoretinal update on the art of gases

5 April 2022 | | EYE - Vitreo-Retinal, EYE - General
The authors remind us of the revolutionary impact gases have had on retinal surgery. In 1938, Rosengren attempted to improve his retina repair surgical outcomes [1]. He discovered that suturing the retina or pressing externally on the sclera were not...

An eye on novel anti-cancer agents: an evidence-based approach to external eye assessment

5 April 2022 | | EYE - Cornea, EYE - General
Novel anti-cancer therapies have led to significant advancement in cancer treatment, however, they can be associated with external eye complications. It is important to be mindful of such adverse effects during assessment of patients enrolled in clinical trials. Annually, approximately...